Publications

5674 Results

The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group (SWOG-8921).

Authors
LE Flaherty;PY Liu;MS Mitchell;WS Fletcher;MJ Walker;JW Goodwin;RL Stephens;VK Sondak
Journal / Conference
American Journal of Clinical Oncology 19(2):108-113
Year
1996
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8921

Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma: A phase II study of the Southwest Oncology Group.

Authors
RA Figlin;JJ Crowley;EL Jacobs;M Muirhead;JW Goodwin;JJ Rinehart;RB Livingston
Journal / Conference
Cancer 78(5):998-1003
Year
1996
Research Committee(s)
Lung
Study Number(s)
SWOG-9127

GM-CSF did not allow doxorubicin dose escalation in the maid regimen: A phase I trial. A Southwest Oncology Group study

Authors
LG Hicks;SP Balcerzak;M Zalupski
Journal / Conference
Cancer Investigation 14(6):507-512
Year
1996
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8922

Phase II evaluation of ifosfamide/mesna in metastatic prostate cancer. A Southwest Oncology Group study.

Authors
SK Williamson;MK Wolf;MA Eisenberger;MA O'Rourke;W Brannan;ED Crawford
Journal / Conference
American Journal of Clinical Oncology (CCT) 19(4):368-370
Year
1996
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8719

Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive and estrogen receptor-positive breast cancer patients: A Southwest Oncology Group study.

Authors
SE Rivkin;S Green;J O'Sullivan;AB Cruz;MD Abeloff;WR Jewell;JJ Costanzi;WB Farrar;CK Osborne
Journal / Conference
Journal of Clinical Oncology 14(1):46-51
Year
1996
Research Committee(s)
Breast
Study Number(s)
SWOG-7827

Intraperitoneal mitoxantrone or floxuridine: Effects on time-to-failure and survival in patients with minimal residual ovarian cancer after second-look laparotomy-A randomized phase II study by the Southwest Oncology Group.

Authors
FM Muggia;PY Liu;DS Alberts;DL Wallace;RV O'Toole;KY Terada;EW Franklin;GW Harrer;DA Goldberg;EV Hannigan
Journal / Conference
Gynecologic Oncology 61:395-402
Year
1996
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8835

Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: An analysis of two intergroup studies.

Authors
KS Albain;SR Green;AS Lichter;LF Hutchins;WC Wood;IC Henderson;JN Ingle;J O'Sullivan;CK Osborne;S Martino
Journal / Conference
Journal of Clinical Oncology 14(11):3009-3017
Year
1996
Research Committee(s)
Breast
Study Number(s)
SWOG-8814, SWOG-8897

Costs of quality-of-life research in Southwest Oncology Group trials

Authors
CM Moinpour
Journal / Conference
Journal of the National Cancer Institute Monographs 20:11-16
Year
1996
Research Committee(s)
Cancer Control

Multidrug resistance-1 (MDR1) expression and functional dye/drug efflux is highly correlated with the t(8;21) chromosomal translocation in pediatric acute myeloid leukemia.

Authors
L Pearson;CP Leith;MH Duncan;IM Chen;T McConnell;K Trinkaus;K Foucar;CL Willman
Journal / Conference
Leukemia 10:1274-1282
Year
1996
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-9007

Correlation of PML-RARa mRNA transcript type with morphology, cytogenetics and clinical parameters in actue promyelocytic leukemia.

Authors
D Viswanatha;KJ Kopecky;K Doss;C Rankin;DR Head;RE Magenis;FR Appelbaum;CL Willman
Journal / Conference
Intl Academy of Pathology Book of Abstracts :125A(#730)
Year
1996
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9007, SWOG-9129 (INT-0129)